baber/WOPTO huggingface dataset:
Patent CA-2416535-A1 (CA)
Title: Non-sedating barbiturate compounds as neuroprotective agents
Inventor: YACOBI AVRAHAM
IPC: A61P9/00
Filed: 2001-07-26
Abstract: Methods of providing neuroprotection are disclosed comprising administering a non-sedative barbiturate compound in an amount sufficient to achieve neuroprotection in a mammalian subject. Preferred compounds are in the family of diphenylbarbituric acid and analogs. Preferred doses for a neuroprotective effect exceed the dosage of a corresponding sedative barbiturate without sedative side-effects such as anesthesia and death.
Patent CA-2418851-A1 (CA)
Inventor: HON SIU CHEONG ELLIS
IPC: F21W107/00
Filed: 2001-06-18
Abstract: A flashlight (10) configured to durably provide an effective beam of light for extended periods of time. The flashlight (10) features a high-power, directed LED (60) configured to produce a divergent beam of light (64) that is characterized by an optical directivity angle (68) extending from a vertex point. The flashlight includes a lens (14) having a first portion forming a convergent lens (82), where the LED (60) is located such that its vertex point coincides with the lens' focal point. The convergent lens is sized and positioned such that substantially all of the directed light from the LED  passes through the convergent lens portion (82) to emerge in a first beam of parallel light (110). The LED (60) emits additional light (120) through a tip (66). A parabolic reflector (92) has the tip (66) at its focalpoint to reflects the additional light into a second beam of parallel light (122) that is parallel to and surrounding the first beam (110), thus forming a single and more efficient useful beam. The LED (60) and parabolic reflector (92) are formed into an illuminator assembly (16) that is contained within a housing (12,18) of the flashlight so as to hold the LED (60) in alignment with its preferred position with respect to the parabolic reflector (92).
Patent CA-2420837-A1 (CA)
Inventor: REDISKE JAMES E
IPC: C08K3/08
Filed: 2003-03-04
Abstract: The present invention relates to a composition containing A) a polymer, B) a pigment or a dye and C) ZnO as a stabilizer, wherein the initial CIELab value .DELTA.E of the stabilized pigmented polymer is less than 10 compared to the pigmented polymer and the reduction of OE of the stabilized pigmented polymer after 750 kj UV radiation is at least 10 % compared to the pigmented polymer.
Patent CA-2423701-A1 (CA)
Title: Oxidoreductases
Inventor: LEE ERNESTINE A
IPC: C07K19/00
Filed: 2001-09-28
Abstract: The invention provides human oxidoreductases (OXIRED) and polynucleotides which identify and encode OXIRED. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of OXIRED.
Patent CA-2426386-A1 (CA)
Inventor: HESSE JOHN E
IPC: H04Q11/04
Filed: 2001-10-19
Abstract: L'invention concerne une structure d'interconnexion et un procédé de communication de messages dans ladite structure d'interconnexion, qui permettent à des messages hautement prioritaires de circuler à travers la structure d'interconnexion à un débit plus rapide que pour les messages de priorité normale ou de basse priorité. Une structure d'interconnexion comprend plusieurs noeuds couplés sélectivement par plusieurs lignes d'interconnexion dans une structure hiérarchisée à plusieurs niveaux. Les données se déplacent d'un point de départ le plus élevé à un point d'arrivée le plus bas. Des noeuds dans la structure sont arrangés en colonnes et en niveaux. Des données ménagent des trous de vers à travers la structure et, dans un intervalle de temps donné, des données se déplacent toujours d'une colonne à une colonne adjacente sur le même niveau ou vers un niveau inférieur. Lorsque des données se déplacent vers un niveau inférieur, un bit supplémentaire de la sortie cible est arrangé de sorte que les données remontant de la base de la structure arrivent au port de sortie cible approprié.
Patent CA-2428142-A1 (CA)
Title: Luminous device providing warning and indication of emergency exit
Inventor: COLBERG JOACHIM
IPC: G08B17/00
Filed: 2003-05-01
Abstract: The luminous alarm alert and danger warning has luminous emergency indicators (2A) with a control unit (3A) controlling the luminous indicator. The indicator can be set in three states. The first a standby state, the normal state a continuous light state. The second, an alert state with discontinuous light indicating urgent evacuation of the area. A third state indicates emergency evacuation with aid being obtained.
Patent CA-2430044-A1 (CA)
Inventor: STANZEL MANFRED
IPC: G01N27/327
Filed: 2001-11-26
Abstract: L'invention vise à améliorer le procédé connu de recyclage redox en ce qui concerne la technique de mesure, par la mesure sans courant du potentiel redox formé par un couple redox au niveau d'une électrode de référence. Un agencement correspondant à ce procédé contient un système à au moins trois électrodes, comprenant au moins une électrode de travail, une contre-électrode et une électrode de référence. Selon l'invention, l'électrode de référence (R) est placée de façon à être adjacente à au moins des zones partielles des deux autres électrodes (W¿ox?, W¿red?, C), et de préférence à égale distance de ces zones partielles. Le système d'électrodes convient dans le cadre du recyclage redox, par exemple, à la détection de réactions d'identification couplées à une enzyme, mais également à la mesure d'une pression partielle d'oxygène (pO¿2?) ou du peroxyde d'hydrogène (H¿2?O¿2?).
Patent CA-2431237-A1 (CA)
Title: Valves and pumps for microfluidic systems and method for making microfluidic systems
Inventor: JEON NOO LI
IPC: F16K15/16
Filed: 2002-01-08
Abstract: The present invention relates to microfluidic systems, including valves (12) and pumps for microfluidic systems. The valves of the invention include check valves (30) such as diaphragm valves and flap valves. Other valves of the invention include one-use valves (12). The pumps of the present invention include a reservoir (40) and at least two check valves (30, 31). The reservoir (40) may be a variable volume. The present invention also relates to a flexible microfluidic system (10). The present invention additionally relates to a method of making microfluidic systems (10) including those of the present invention. The method includes forming a microfluidic system on a master (100), connecting a support (110) to the microfluidic system (10) and removing the microfluidic system (10) from the master (100). The support (110) may remain connected to the microfluidic system (10) or the microfluidic system (10) may be transferred to another substrate. The present invention further relates to a method of manipulating a flow of a fluid in a microfluidic system. This method includes initiating fluid flow in a first direction (50) and inhibiting fluid flow in a second direction (50) and may be practiced with the valves (12) of the present invention.
Patent CA-2431374-A1 (CA)
Title: Nouveaux facteurs de croissance du fibroblaste
Inventor: FAULDS DARYL
IPC: C12N15/18
Filed: 2001-12-10
Abstract: L'invention porte sur de nouveaux acides nucléiques, sur des séquences polypeptidiques et sur leurs régulateurs qui ont été identifiés avec un code associé à un facteur de croissance du fibroblaste (FGF), de préférence FGF-20 ou FGF-23, sur une classe de polypeptide impliquée dans son développement, dans la différenciation et la morphogenèse, notamment la signalisation cellule-cellule et la prolifération cellulaire. Un FGF, les fragments et ses dérivés bénéficient d'une ou plusieurs activités biologiques suivantes: la stimulation de la cicatrisation de blessures; la stimulation de la survie cérébrale; la stimulation de la prolifération cellulaire, dont la prolifération de cellules souches, de fibroblastes, de neurones, de névroglies, d'oligodendrocytes, de cellules Schwann ou de leurs progéniteurs; la modulation de la différenciation des cellules, la stimulation du développement de l'embryon, la stimulation de l'excroissance des neurites; un rétablissement facilité après des lésions nerveuses ou cérébrales; la stimulation de la myélinisation; la stimulation de l'angiogenèse; l'amélioration de l'activité de liaison des récepteurs et la modulation de la tumorigenèse.
Patent CA-2432251-A1 (CA)
Inventor: WATANABE SHUJI
IPC: C03C25/27
Filed: 2003-06-12
Abstract: Fiber for reinforcing rubber products, which comprises fiber having a first coating film formed by a first coating agent comprising a condensate of resorcinol and formaldehyde, and a rubber latex, wherein the fiber has a second coating film formed by a second coating agent comprising an uncured phenol resin and a rubber, on the first coating film.
Patent CA-2433123-A1 (CA)
Title: Conveyorable plastic thermoformed pallet and method for making pallet
Inventor: HOLMES MARK A
IPC: B65D19/00
Filed: 2003-06-17
Abstract: A Conveyorable Plastic Thermoformed Pallet, having a support member and support legs with outer walls, internal walls and inner walls, is utilized to transport product on a conveyor system. The Pallet is made using a twin-sheet thermoforming process that requires two molds for an upper sheet of thermoplastic material and a lower sheet of thermoplastic material. The upper sheet forms a top deck of the support member and the internal walls of the support legs. The lower sheet forms the underside of the support member, the inner walls of the support legs, and leg bottoms. Both sheets are fused to form the twin-sheet outer walls. The upper sheet also forms web strips which stabilize the walls of the support legs and prevent deflection of the walls.
Patent CA-2436147-A1 (CA)
Inventor: BIRNBAUM ULRICH
IPC: A47B57/42
Filed: 2003-07-29
Abstract: An assembly element for the temporary holding and securing a first component on at least one second component includes an insertion section (2;  22; 32) having at least one receptacle (6; 25, 26; 33, 34) for receiving a fastening element (10) for attaching the first component to the second component (11), and a holding section (3; 23; 35) adjoining the insertion section (2; 22; 32) and extending substantially transverse to a plane defined by the insertion section (2; 22;  32).
Patent CA-2437007-A1 (CA)
Inventor: OMATSU TADASHI
IPC: C09D11/00
Filed: 2002-01-18
Abstract: According to the present invention, a novel phthalocyanine compound having a specific structure is provided, and an ink, an inkjet recording ink, an inkjet recording method and a method for improving preservability of a formed image, each using the compound, are also provided.     The novel phthalocyanine compound of the present invention has a sufficiently high fastness to light, heat, humidity and active gases in the environment and by using an ink, particularly inkjet recording ink, containing the phthalocyanine compound, an image having high fastness to light and ozone gas in the environment can be formed.
Patent CA-2439489-A1 (CA)
Title: Preparation of warfarin sodium from warfarin sodium-2-propanol clathrate by solvent expulsion
Inventor: ULANENKO KONSTANTIN
IPC: A61K31/353
Filed: 2001-12-28
Abstract: The present invention is a method for producing warfarin sodium from warfari n sodium 2-propanol clathrate by thermal, nondestructive solvent expulsion. Th e solvent expulsion is conducted under conditions of controlled heat transfer whereby the 2-propanol is expelled from the warfarin sodium 2-propanol clathrate without decomposition of warfarin sodium or the clathrate. Heating is conducted the clathrate at a temperature from about 100 ~C to about 170 ~ C in an active oven under air or in an inert atmosphere and at partial pressur es ranging from that of a relative vacuum to atmospheric pressure. The inventio n also relates to pure warfarin sodium prepared according to the method of the invention and pharmaceutical compositions containing warfarin sodium.</SDOAB >
Patent CA-2441213-A1 (CA)
Title: Cd4+cd25+ regulatory t cells from human blood
Inventor: DIECKMANN DETLEF
IPC: A61K35/17
Filed: 2002-03-12
Abstract: The present invention provides suppressive and/or regulative human CD4+CD25+ T cells, a method for expanding same, and the use of the suppressive and/or regulative human CD4+CD25+ T cells and the expanded T cells as regulatory agent.
Patent CA-2441798-A1 (CA)
Title: Crystalline isoxazole derivative and medical preparation thereof
Inventor: NISHII HIROYUKI
IPC: C07D261/14
Filed: 2002-03-26
Abstract: Crystalline 3-[(1S)-1-(2-fluorobiphenyl-4-yl) ethyl]-5-{[amino(morpholin-4-yl)methylene]amino}-isoxazole that exhibits the following angle of diffraction (20) and relative intensity in a powder X-ray diffraction pattern, is very easy to handle and stable in a process of its formulation into a pharmaceutical preparation.     (see above table)
Patent CA-2442127-A1 (CA)
Inventor: OGURA MUTSUO
IPC: H01L29/12
Filed: 2001-09-28
Abstract: Selon l'invention, sur un substrat InP présentant une rainure en forme de V asymétrique dont un côté est le plan (100) et l'autre côté est le plan (101), est formée une couche de barrage InA1As possédant une tranchée (TR) présentant un côté qui est le plan A (111) et l'autre côté qui est le plan B (331), faisant face l'un par rapport à l'autre. Sur la face inférieure de la tranchée, est formé comme un canal à mobilité élevée, un fil électrique quantique InGaAs possédant une bande d'énergie interdite relativement étroite, sur laquelle est formée une couche dopée à modulation InA1As possédant une bande d'énergie interdite relativement large comme une bande interdite de canal à faible mobilité. Une électrode source et une électrode déversoir sont formées, lesquelles sont électriquement connectées au canal à mobilité élevée par l'intermédiaire d'une couche de contact et espacées l'une de l'autre dans le sens longitudinal du fil électrique quantique, et une électrode grille qui est interposée entre l'électrode source et l'électrode déversoir et fait face au canal à faible mobilité par l'intermédiaire d'une couche isolante ou d'une jonction de Schottky. On obtient ainsi un dispositif à effet de champ caractéristique à résistance négative.
Patent CA-2443732-A1 (CA)
Inventor: HATANAKA TAKAHIRO
IPC: A61P29/00
Filed: 2002-04-12
Abstract: The present invention has revealed the compounds transportable by ATB0,+. Based on the information about these compounds, drugs transportable by ATB0, + may be designed, producedand screened. Such drugs may serve to treat and/or prevent the diseases in which NOS, phenylglycine, carnitine, D-amino NOS, phenylglycine, carnivolved. The ATB0,+ gene may be administered to patients to be used for gene therapy of the diseases as described above.
Patent CA-2444640-A1 (CA)
Title: Long life lubricating oil composition with very low phosphorus content
Inventor: CARTWRIGHT STANLEY JAMES
IPC: C10M163/00
Filed: 2003-10-10
Abstract: A lubricating oil with very low phosphorus content, and having long life as evidenced by a reduction in viscosity increase, oxidation and nitration, comprises a major amount of a base oil of lubricating viscosity and a minor amount of a mixture of neutral and overbased metallic detergents, at least a zinc dialkyldithiocarbamate antiwear additive and at least a dihydrocarbylthiocarbamoyl.
Patent CA-2450791-A1 (CA)
Title: System
Inventor: VAN DER STEEN HEIN
IPC: C12M3/06
Filed: 2002-06-18
Abstract: A micro chamber arrangement for development of oocytes, fertilisation and embryo culture. Objects are kept in a micro environment. The system monitors and regulates the environment for the objects and incorporates regular quali ty control. The device is very suitable for large scale embryo production. The arrangement can be used for follicle sorting, follicular growth, oocyte maturation, oocyte enucleation, in vitro fertilisation, cloning, nuclear transfer, genetic modification, embryo culture, embryo encapsulation and embryo transport.
Patent CA-2451058-A1 (CA)
Title: Nouveaux polypeptides et acides nucleiques, procedes permettant de les produire et leurs utilisations
Inventor: MURPHY ANDREW J
IPC: C07K14/72
Filed: 2002-06-19
Abstract: L'invention concerne des polypeptides GPCR LGR9 humains et des acides nucléiques apparentés. L'invention comprend en outre des homologues GPCR LGR9 humains issus de plusieurs espèces et des polypeptides comprenant un domaine de GCPR LGR9 humains, à activité spécifique. Ces polypeptides sont obtenus par recombinaison de cellules hôtes transformées avec les acides nucléiques objets. L'invention concerne par ailleurs des échantillons d'hybridation isolés et des oligonucléotides amorces, aptes à une hybridation spécifique avec les gènes décrits, des agents de liaison spécifiques et des procédés permettant de produire et d'utiliser les compositions en question, ainsi que des tris à rendement élevé.
Patent CA-2451124-A1 (CA)
Inventor: AHMADIAN HALEH
IPC: C07C215/34
Filed: 2002-07-12
Abstract: A novel method is provided for the manufacture of escitalopram. The method comprises chromatographic separation of the enantiomers of citalopram or an intermediate in the production of citalopram using a chiral stationary phase such as ChiralpakTM AD or ChiralcelTM OD. Novel chiral intermediates for the synthesis of Escitalopram made by said method are also provided.
Patent CA-2451299-A1 (CA)
Inventor: JACKSON MELVIN ROBERT
IPC: C22F1/00
Filed: 2003-11-27
Abstract: A composition of matter is about 1 to about 3 percent rhenium, from about 6 to about 9 percent aluminum, from 0 to about 0.5 percent titanium, from about 4 to about 6 percent tantalum, from about 12.5 to about 15 percent chromium, from about 3 to about 10 percent cobalt, from about 2 to about 5 percent tungsten, from 0 to about 0.2 percent hafnium, from 0 to about 1 percent silicon, from 0 to about 0.25 percent molybdenum, from 0 to about 0.25 percent niobium, balance nickel and minor elements. The composition is preferably made into a substantially single crystal article (18), such as a component (20) of a gas turbine engine.
Patent CA-2453598-A1 (CA)
Title: Antiperspirant product with dibenzylidene sorbitol and elastomer in dimethicone
Inventor: ORTIZ CLAUDIO
IPC: A61K8/34
Filed: 2002-07-15
Abstract: This invention comprises a clear to translucent anhydrous stick or gel antiperspirant and/or deodorant product having low tack and comprising:(a) a solvent phase comprising: (i) 0.2-4.0 weight % dibenzylidene sorbitol; (ii) 0.05 - 1.0 weight % of a co-gellant or structural integrity enhancer; (iii) 25- 75 weight % of a solvent selected from the group consisting of polyhydric alcohols; (iv) an effective amount of an antiperspirant or deodorant; and (v ) 0.1-5 weight % dimethicone copolyol; and (b) an oil phase comprising: (i) 0. 25- 5 weight % of a silicone elastomer (on a solids basis) in a first dimethicon e wherein the dimethicone has a viscosity in the range of 6-100 centistokes an d a flashpoint in the range of about greater than 115 degrees C to 300 degrees C; and (ii) 1-25 weight % of a second dimethicone (including the dimethicone from part (b)(i)), wherein the second dimethicone may be selected from the same group or a different group than the first dimethicone; and (iii) 0-10 weight % emollients; wherein the oil phase is 5-50% of the composition and t he solvent phase is 50-95% of the composition.
Patent CA-2454846-A1 (CA)
Title: Integrated engine - jet pump drive unit for marine application
Inventor: KUSEL HEINZ
IPC: B63H21/14
Filed: 2004-02-09
Abstract: A watercraft includes a shell, a ride plate, an internal combustion engine, and a jet pump. The shell defines a tunnel that extends forwardly from the transom and is defined laterally by the shell. The tunnel is open at its bottom The ride plate mounts to the shell under the tunnel. The engine and jet pump are supported by the ride plate and disposed in the tunnel. The engine drives the jet pump. The engine is cooled by water that continuously flows past the ride plate. The engine, jet pump, and ride plate are installed from below or the behind the shell.
Patent CA-2457459-A1 (CA)
Title: Resolution of racemates of methyl alpha-5-(4,5,6,7-tetrahydro(3,2-c)thienopyridyl)-(2-chlorophenyl) acetate
Inventor: BEJAN ELENA
IPC: C07D495/04
Filed: 2004-02-11
Abstract: A process for the resolution of each of the enantiomers of methyl-.alpha.-5-[4,5,6,7-tetrahydro[3,2-c]thienopyridyl]-(2-chlorophenyl)acetate and salts thereof by diastereomeric crystallization comprising the use of a single optically active resolving agent and at least one solvent.
Patent CA-2463754-A1 (CA)
Inventor: WEARLEY LORRAINE L
IPC: A61P31/10
Filed: 2002-10-15
Abstract: Cette invention concerne de nouvelles compositions, des méthodes d'utilisation, des schémas posologiques, et des kits destinés au traitement d'infections bactériennes et fongiques locales qui sont sensibles à un traitement administré de manière locale ou topique et systémique. Lesdites méthodes de l'invention ont également trait à des façons de soulager les symptômes de telles infections dans un temps d'exécution inopinément plus court que celui d'un traitement traditionnel, avec une prévisibilité plus importante qu'avec les méthodes connues actuellement.
Patent CA-2464894-A1 (CA)
Title: Colorectal cancer prognostics
Inventor: WANG YIXIN
IPC: C12Q1/68
Filed: 2004-03-30
Abstract: A method of providing a prognosis of colorectal cancer is conducted by analyzing the expression of a group of genes. Gene expresson profiles in a variety of medium such as microarrays are included as are kits that contain them.
Patent CA-2466035-A1 (CA)
Title: Procede et instrument de chirurgie de la cataracte
Inventor: ANTHONE KENNETH D
IPC: A61B/
Filed: 2002-11-08
Abstract: La présente invention concerne un procédé supracapsulaire permettant l'ablation de cataractes de façon efficace, fiable et simple. Selon ledit procédé : une rainure est pratiquée dans le noyau de la cataracte ; le noyau est fendu le long de la rainure en deux moitiés, et subit une rotation de 90 degrés ; une force est appliquée à la moitié proximale pour faire prendre à la moitié distale une position d'empilement par rapport à la moitié proximale ; et les moitiés de noyau sont ensuite émulsionnées et éliminées avec le reste de la cataracte. Afin de minimiser les risques de traumatisme de la capsule au cours du retrait de la capsule du cristallin des parties de cataracte et au cours de la formation de la fente dans le noyau, et pour favoriser la manipulation de parties du noyau, est utilisé un instrument qui présente une partie de fixation à la cataracte dépourvue de pince, ayant de préférence un bord frontal convexe.
Patent CA-2466987-A1 (CA)
Title: Machines motrices post mecaniques, retromecaniques, et bi mecaniques (conclusion: ajouts interpretatifs)
Inventor: BEAUDOIN NORMAND
IPC: F01C1/00
Filed: 2004-04-26
Abstract: La présente invention a pour objet de compléter nos inventions antérieures en donnant d'autres exemples de méthodes de soutient des parties compressives des machines motrices rotativo-circulaires, de même qu'en ajoutant quelques commentaires relatif à l'interprétation du mouvement des parties compressives desquelles elles sont munies, et ce de manière a ce que cet objet soit bien cerné.